ASTELLAS PHARMA INC.

Calendar Astellas Pharma Inc. OTC Markets

Stocks

ALPMY

US04623U1025

Pharmaceuticals

Market Closed - OTC Markets Other stock markets 15:59:52 2026-07-31 EDT			5-day change	1st Jan Change
13.73 ^USD	-4.79%		+4.89%	+3.31%

07-12	Pfizer, Astellas Secure FDA Nod For Bladder Cancer Drug	MT
07-10	Health Care Down on Rotation Back to Tech - Health Care Roundup	DJ

Chart calendar Astellas Pharma Inc.

1ba5ef5f60d0.64H5__AvP30YCwg4kKkTgYz85brfM69Bi4TW8BclDao.qrnAmYd3RRtUOFB9ypB6zeCJpM7seZkO3OaRyUZfQ9i427u1gBkLCG85PA~fff26370dffcbe4afcb0cf97eb96049b

Upcoming events on Astellas Pharma Inc.

2026-08-05	Earnings release - Q1 2027	02:30
2026-08-05	Earnings presentation	03:00
2026-09-29	Ex-dividend date - 40 JPY	00:00

Past events on Astellas Pharma Inc.

2026-06-18	Présentation aux Actionnaires / Analystes	21:00
2026-06-18	Annual General Meeting
2026-06-03	Analyst/Investor Day	08:10
2026-05-26	Information meeting	03:00
2026-05-14	Board of Directors Meeting
2026-04-27	Earnings release - Annual 2026	02:30
2026-04-27	Earnings presentation	03:00
2026-04-26	Board of Directors Meeting
2026-03-30	Information meeting	20:01
2026-02-25	Analyst/Investor Day	20:00
2026-02-04	Earnings release - Q3 2026	01:30
2026-02-04	Earnings presentation	02:00
2025-12-08	Information meeting	19:01
2025-10-30	Earnings release - Q2 2026	02:30
2025-10-30	Earnings presentation	03:15
2025-10-23	Information meeting	20:01

Past dividends on Astellas Pharma Inc.

2026-03-30	Ex-dividend date - 39 JPY	00:00
2025-09-29	Ex-dividend date - 39 JPY	00:00

Annual results

Fiscal Period	March	2024	2025	2026	2027	2028	2029
Net sales Million JPY	Released Forecast Spread	1 603 672 1 571 972 2.02%	1 912 323 1 879 783 1.73%	2 139 245 2 132 090 0.34%	2 259 518	2 079 011	1 843 965
EBITDA Million JPY	Released Forecast Spread	183 358 264 920 -30.79%	240 171 382 224 -37.16%	577 227 606 543 -4.83%	651 031	625 569	510 234
EBIT Million JPY	Released Forecast Spread	25 518 89 542 -71.5%	41 039 49 953 -17.84%	382 633 408 040 -6.23%	455 432	436 500	345 577
Earnings before Tax (EBT) Million JPY	Released Forecast Spread	24 969 24 853 0.47%	31 237 27 715 12.71%	376 587 374 105 0.66%	429 225	415 482	293 031
Net income Million JPY	Released Forecast Spread	17 045 13 409 27.12%	50 747 26 466 91.74%	291 535 296 438 -1.65%	342 532	330 764	248 432
EPS JPY	Released Forecast Spread	9,51 13,2 -28.05%	28,4 15,9 78.26%	163 171 -4.77%	191	185	139
Announcement Date		25/04/24	25/04/25	27/04/26	-

Quarterly results

Fiscal Period	March	2025 Q2	2025 S1	2025 Q3	2025 Q4	2026 Q1	2026 Q2	2026 S1	2026 Q3	2026 Q4	2027 Q1	2027 Q2	2027 S1	2027 Q3	2027 Q4
Net sales Million JPY	Released Forecast Spread	462 497 425 282 8.75%	935 621 916 183 2.12%	517 408 433 900 19.25%	459 294 448 340 2.44%	505 794 466 640 8.39%	524 320 480 396 9.14%	1 030 114 945 286 8.97%	571 206 532 886 7.19%	537 925 516 347 4.18%	561 608	579 258	1 143 073	612 702	508 085
EBITDA Million JPY	Released Forecast Spread	93 070 59 074 57.55%		-65 027 84 050 -177.37%	111 203 76 300 45.74%	142 451 107 950 31.96%	152 025 128 850 17.99%		183 638 139 900 31.26%	99 163 120 397 -17.64%	181 450	173 350		212 950	82 950
EBIT Million JPY	Released Forecast Spread	43 053 52 879 -18.58%	93 710 128 279 -26.95%	-116 191 43 250 -368.65%	63 520 23 452 170.85%	94 647 41 262 129.38%	104 731 68 833 52.15%	199 378 60 979 226.96%	134 502 107 511 25.11%	48 803 62 750 -22.23%	135 080	139 767	258 243	151 433	64 600
Earnings before Tax (EBT) Million JPY	Released Forecast Spread	38 547 57 286 -32.71%	89 042 124 879 -28.7%	-118 359 77 375 -252.97%	60 554 59 417 1.91%	90 416 35 332 155.9%	104 190 60 848 71.23%	194 606 55 979 247.64%	133 957 102 166 31.12%	48 024 81 000 -40.71%	123 400	148 000	253 243	129 800	35 900
Net income Million JPY	Released Forecast Spread	35 908 41 367 -13.2%	73 511 93 206 -21.13%	-97 660 54 894 -277.91%	74 896 46 749 60.21%	68 422 27 527 148.56%	79 213 46 074 71.93%	147 635 48 701 203.15%	100 379 78 412 28.01%	43 521 64 329 -32.35%	106 592	115 099	192 465	121 994	34 167
EPS JPY	Released Forecast Spread	20,1 16,0 25.65%	41,1 39,4 4.21%	-54,6 8,07 -776.31%	41,8 4,30 873.37%	38,2 18,1 111.21%	44,2 28,9 53.25%	82,4 27,2 203.09%	56,0 42,4 32.03%	24,3 21,4 13.31%	51,0	53,0	108	57,6	21,6
Announcement Date		30/10/24	30/10/24	04/02/25	25/04/25	30/07/25	30/10/25	30/10/25	04/02/26	27/04/26	-	-	-	-	-

Upcoming sector events for Astellas Pharma Inc.

Today	DIVI'S LABORATORIES LIMITED	Earnings release - Q1 2027
Today	DIVI'S LABORATORIES LIMITED	Earnings presentation	04:30
Today	SUZHOU ZELGEN BIOPHARMACEUTICALS CO., LTD.	Earnings release - Q2 2026
2026-08-02	SHIONOGI & CO., LTD.	Earnings release - Q1 2027	P
2026-08-02	GLAXOSMITHKLINE PHARMACEUTICALS LIMITED	Présentation aux Actionnaires / Analystes
2026-08-02	GLAXOSMITHKLINE PHARMACEUTICALS LIMITED	Board of Directors Meeting
2026-08-02	BLUE JET HEALTHCARE LIMITED	Earnings release - Q1 2027
2026-08-02	BLUE JET HEALTHCARE LIMITED	Board of Directors Meeting
2026-08-02	MOCHIDA PHARMACEUTICAL CO., LTD.	Earnings release - Q1 2027	P
2026-08-02	SENORES PHARMACEUTICALS LIMITED	Extraordinary General Meeting

Past sector events for Astellas Pharma Inc.

2026-07-31	ABBVIE INC.	Earnings presentation	09:00
2026-07-31	ABBVIE INC.	Earnings release - Q2 2026
2026-07-31	DAIICHI SANKYO COMPANY, LIMITED	Earnings release - Q1 2027
2026-07-31	DAIICHI SANKYO COMPANY, LIMITED	Earnings presentation	04:30
Today	DIVI'S LABORATORIES LIMITED	Board of Directors Meeting
2026-07-31	ZHANGZHOU PIENTZEHUANG PHARMACEUTICAL CO., LTD.	Ex-dividend date - 1.57 CNY	00:00
2026-07-31	AMNEAL PHARMACEUTICALS, INC.	Extraordinary General Meeting	09:00
2026-07-31	SUMITOMO PHARMA CO., LTD.	Earnings release - Q1 2027
2026-07-31	SUMITOMO PHARMA CO., LTD.	Earnings presentation	03:30
2026-07-31	ASTRAZENECA PHARMA INDIA LIMITED	Ex-dividend date - 36 INR	00:00

Quarterly revenue - Rate of surprise

Net sales - Rate of surprise

Annual profits - Rate of surprise

Stock Market
Stocks
4503 Stock
ALPMY Stock
Calendar Astellas Pharma Inc.

As early as today, start finding the best investment opportunities!